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2Abstract
The provision of performance information is essential for ensuring and improving the performance
of health care systems. However, the lack of reliable quality information is a key problem in
evaluating and improving health care. This paper estimates the performance of English NHS
Acute Trusts using Dr. Foster data from the years 1996 – 2008 to investigate health outcomes
after elective treatment for Acute Myocardial Infarction (AMI) and Hip Replacement. A latent
variable approach is used to calculate the hospital quality eﬀect in determining short and long
term mortality and readmission rates for each year. These measures are then used to compare
current and past quality of care within and across NHS Acute Trusts. Our results support that
this method is well suited to measuring provider quality of care. Using these quality measures we
are able to investigate the performance of NHS Acute Trusts across this time period and identify
hospitals where further scrutiny of low quality is required in the future.
Keywords: Measuring Quality; Latent Variables; Health.
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4 1 Introduction
1 Introduction
Often timely and relevant data on quality of care does not exist, because it is costly and
diﬃcult to collect. Yet, even when such data is available it is not straightforward to
use. We are still far from having complete data sets informing us of all the factors that
influence outcomes, or measures for the appropriate clinical processes of care required to
obtain good outcomes. Indeed, while work on the evidence base of medicine is growing,
and many conditions have been identified as amenable to health care (Holland, 1988; Nolte
et al., 2004), there still remains considerable uncertainty about the clinical eﬀectiveness
of over half of current medical practice (Tovey, 2007; Maynard, 2008). Even with good
data, multidimensionality is a problem - as quality of medical care has many dimensions:
outcomes, processes and others - ideally all of which would be integrated into a quality
evaluation (McClellan and Staiger, 1999).
Increasingly measures of health outcome are used to inform policy, whether it is through
investigations into surgical performance (Spiegelhalter et al., 2002), to produce publicly
available indicators of performance for hospitals (Healthcare Commission, 2004; New York
State Department of Health, 2004), or to produce research to evaluate health care reforms
(Farrar et al., 2009; Jarman et al., 1999). Use of outcomes to compare quality of care
assumes that variation attributable to other factors can be properly accounted for, such
that any residual variation in outcomes, such as observed mortality and morbidity, is
indicative of variation in quality of care (Lilford et al., 2004).
While outcome measures are influenced by quality of care they are also a result of data
collection techniques, data quality, patient case-mix, and chance. Definitions of outcomes
can vary considerably across institutions influencing the comparability of data. Even with
a simple outcome such as death, systematic diﬀerences can arise with definitions and the
way they are applied across institutions, for example by classifying patients who come to
the hospital to die under the palliative code Z51.5 or not (Hawkes, 2010a). Moreover,
trying to identify groups, or cases, of patients whose outcome is being compared can also
be diﬃcult. Some cases such as Child Birth or Fractured Neck of Femur are very easy
to identify, but other areas such as Stroke or Infertility are harder to classify, and data
coding and collection may vary across institutions (Lilford et al., 2004). Both these issues
pose challenges in using data for to compare providers.
The type of information will also diﬀer markedly when obtained from diﬀerent sources
such as case records or administrative data. Routine administrative data often contains
little information on co-morbidity and severity of disease which will have a large impact
5on outcome. Clinical databases, run by various bodies, may record more detailed clinical
information, but are also likely to vary considerably with regards to data quality (Aylin
et al., 2007). In England, HES is often regarded as unreliable by clinicians because of
problems in its early years, notably its inability to secondary diagnoses for most patients
(McKee and James, 1997; McKee et al., 1999). However, since then data quality has
improved considerably (Audit Commission, 2004). Indeed Aylin et al. (2007) note that,
“if suitable predictive models could be developed using this routinely collected information
source, they would be a valuable tool for generating measures of performance adjusted for
case mix”.
The most commonly discussed challenge of using outcome measures as a quality met-
ric is accounting for diﬀerences in patient case-mix. Fair comparison of quality between
providers needs to consider the diﬀerences in patient factors that will influence outcomes,
such as patient severity or co-morbidity. Typically, some sort of risk adjustment is em-
ployed to address the attribution problems associated with outcome measures, and control
for the other influencing factors. Yet, even when outcome measures are risk adjusted, as
is the case for hospital standardised mortality ratios (HSMRs) for example, they still run
the risk of not accounting for factors that cannot be identified and measured accurately.
Mistaking such errors for diﬀerences in quality is known as “case-mix fallacy” (Lilford
et al., 2004).
Finally, we should not forget the presence of random error, which is inherent to any
measurement. Random error can take the form of type 1 (false negatives) or type 2 (false
positives) error. The only way to limit the amount of both types of error is to ensure
the sample size is large enough. Unfortunately this is not always possible when dealing
with health care, as it depends on the prevalence of particular treatments and conditions.
Many studies have noted the challenges associated with sample size and outcomes, which
limit the number of procedures that can be assessed (Birkmeyer et al., 2002; Dimick et al.,
2004).
In using outcome measures as quality metrics, the challenge lies in controlling for all
these factors in order to extract the true quality signal from the measure. With the
exception of chance, every other factor has components that can be measured and others
that cannot (Lilford et al., 2004). Case-mix adjustment is often used to control for variance
in outcome, indeed there is a wide literature on diﬀerent statistical methods used to
produce case-mix adjusted outcomes (Jarman et al., 2005; Iezzoni, 1994; Iezzoni et al.,
1996; Iezzoni, 1997; Shahian et al., 2001, 2010). However, worryingly enough diﬀerent
case-mix adjustment methods can produce diﬀerent results, identifying diﬀerent providers
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as good or bad performers depending on the adjustment technique used (Iezzoni et al.,
1996; Shahian et al., 2010).
Even if a case-adjustment technique was uniformly applied to providers outcomes could
still vary systematically across providers due to diﬀerences in the other areas. For example,
outcomes could diﬀer because of systematic factors such as systematic diﬀerences in data
recording, or systematic diﬀerences to patient behaviours before and after treatment. For
example, hospitals that treat less educated patients may have worse outcomes because they
have lower adherence to medications after treatment. An alternative method to control for
noise was put forward by McClellan and Staiger (1999) who used information on individual
patient characteristics at the individual hospital level to adjust hospital quality measures
at the hospital level and thus take account of any systematic biases which are embedded
within these measures. The approach, in recognition that the measurement of hospital
quality is diﬃcult, begins with latent variable approach to address measurement issues,
before going on to refine this measure with a vector autoregression framework.
A latent variable is a variable that can not be observed directly, such as hospital quality.
Latent variable assessment takes the observable data and combines it to make assump-
tions about the unobservable, latent, phenomenon. The latent variable measured by this
method will consist of the ‘true’ variance with both random and systematic errors. This
type of technique has been used extensively in the areas of psychological and education
testing (Hambleton and Cook, 1977), political science (Treier and Jackman, 2008), and in-
creasingly in epidemiology (Muthén, 1989). In educational testing, information is collected
about the subject’s ability through their answers on various questions which are indicative
of their underlying ability. Conditional on the latent trait, the multiple responses are
assumed to be independent observations, and thus correlation amongst the responses is
induced by variability in the latent ability amongst the subjects. Thus by modelling their
responses the latent ability can be estimated (Landrum et al., 2000).
This model can be extended to health, where the latent trait being modelled is provider
quality. By using hospital-specific intercepts derived from a patient level equation which
maps quality of outcome (e.g. 30-day mortality) against patient characteristics we are able
to create latent measures of quality, as they pick up the unmeasured systematic aspects
which are retained after controlling for observable variation in patient outcomes. While
these latent outcome measures will still be noisy, they will filter out much of the estimation
error that is otherwise present due to systematic diﬀerences in patient mix across hospitals
rather than diﬀerences in care. Additionally, as these estimates are normally calculated
using large samples of patients it is possible to eliminate much of the noise inherent
7in raw outcome measures, that make quality measures diﬃcult to interpret. While a
latent variable approach is essentially another case-mix adjustment technique it is an
improvement to other methods as the latent measure provides a composite measure of
quality for each provider than result in diﬀerent outcomes.
These latent outcome estimates of hospital quality thus have a number of attractive fea-
tures. They can incorporate information on quality measures in a systematic manner, are
relatively easy to compute from available data and overcome the risk of over-estimation
which is common when aggregate data are combined with individual observations. These
hospital intercepts, which estimate the mean value of quality measure holding patient
characteristics constant, are therefore less noisy and less likely to be inconsistent esti-
mates than crudely observed aggregate measures of hospital quality. In this paper, we will
explore the use of latent variable modelling to measure quality of health care providers.
We find that this methodology can be useful for quality measurement in situations where
random or systematic measurement error is a problem, where the phenomenon under study
is not directly observable, and where many indicators are needed to describe the diﬀerent
aspects of the phenomenon. The next section will outline the empirical methods used in
the paper, before we go on to describe the data used for the model. Finally, we will present
the results of the analysis and conclude.
2 Empirical Model
This paper introduces the basic approach which analyses the determinants of hospital
quality through a two-step process, with hospitals being the unit of analysis. In the first
step, individual patient level data is used to create latent outcome measures at the hos-
pital level using multiple individual outcome measures (mortality and readmission rates),
adjusted for individual level patient characteristics. This process allows the amount of
noise surrounding these outcome measures to be minimized, thus creating more robust
quality measures at the hospital level. The latent outcome measures are then used in the
second step to examine how diﬀerent hospital and social characteristics influence quality
of care.
2.1 Creating Latent Outcome Measures
The first step of the analysis uses the quality measures provided at the individual patient
level over a given amount of years to estimate the relative diﬀerence in the mean value
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of outcomes of each hospital holding patient characteristics constant. These hospital
intercepts are estimated using the following equation:
Y kiht = βqk1h +
￿
φXjht + uiht , (1)
where Y k represents the quality outcome measure (mortality and readmission rates at
diﬀerent time intervals), with i denoting the individual patient, h the hospital and t the
year. ￿φ represents a group of individual control variables for patient characteristics
(age, gender, socioeconomic deprivation, co-morbidities and type of admission). While β
represents the fixed eﬀects of all NHS hospitals in which treatment was provided to the
sample of patients. The model is run with no constant term, and thus a variable for every
hospital can be included. As there is no reference case, the βk coeﬃcients will represent
the intercept value of the hospital’s mortality/readmission regression.
This patient level regression is run separately for each year t and quality outcome mea-
sure k. By saving the βk coeﬃcients for each regression, we obtain a vector of hospital
intercepts for each quality outcome measure k, and year t. These estimates of quality are
appealing as they provide relative rankings of hospital performance contributing to the
quality outcomes, controlling for other observable influences. These estimates thus allow
some of the noise to be removed from the outcome measures, and thus enable a more
appropriate comparison of hospital trusts to one another.
2.2 Panel Data Estimation with Lagged Variables
Just as the performance of hospitals in obtaining a desired outcome for their patients will
be influenced by the characteristics of patients, it will also depend on other factors such
as the characteristics of the hospital itself. The second step of this analysis uses the latent
quality measures calculated in the manner explained above and examines how they are
associated with key hospital characteristics. This will inform us about what factors our
quality metrics are associated with, but can also help draw conclusions about how well
the latent indicator performs.
Hospital performance is likely to be influenced by hospital characteristics such as the type
of hospital. Diﬀerent types of hospitals (teaching, acute, specialist, foundation) may be
associated with diﬀerent quality care because of diﬀerent underlying incentives or manage-
ment models. For example, in addition to delivering medical care to patients, a teaching
hospital will also provide clinical education and training to future health professionals, and
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also invests in research and technology. These functions may result in diﬀerent objectives
and managerial style which can also contribute to quality diﬀerences. Specialist trusts
and foundation trusts were introduced to the NHS in 2004. Specialist trusts are dedicated
to providing elective care, while a foundation trust is a high performing hospital that has
received more managerial and financial freedoms. These diﬀerences are likely to have an
eﬀect on hospital performance.
Other factors such as the number of patients treated (caseload) may also contribute to
overall performance. The relationship between cases and outcomes is not clear. Increased
caseload may result in lower quality due to overcrowding, or it can result in higher caseload
as doctors become more experienced. Moreover, higher quality may lead to more cases
as demand increases, or it can be the result of selecting fewer cases. Similarly average
deprivation and co-morbidity is likely to be correlated with the latent outcome measure if
there is a confounding relationship between them, that is if they are both correlated with
another variable that influences quality. For example if more deprived patients are less
likely to adhere to treatment after being discharged and thus are more likely to have bad
outcomes.
However, it is unlikely that hospital performance is instantaneously influenced by a change
in any of these variables, because of institutional, technological or even psychological
reasons (Gujarati, 2003). In an institution structural forces dominate, at least in the
short term. For example contractual obligations may prevent hospitals from switching
sources of labour, on ancillary services immediately. Thus in certain regards institutions
are ‘locked in’ to current conditions, at least until the medium term. Technological reasons
may relate to the adoption of medical innovations. There will be a time gap between the
introduction of a new technology and its adoption in routine health service provision.
Finally, the psychological factors refer to the inertia of the status quo, managers and
employers take time to adjust to change, thus even if some other factor such as changes
in prices occur it may take a transition period for this change to translate into behaviour.
Moreover, the performance of a hospital is likely to depend on its past performance. Thus
it is important to consider how lags of hospitals own performance, as well as of the other
explanatory variables influence the latent variable.
In order to examine the relationship between the exogenous factors discussed above and
hospital performance, as measured by the latent variable, the following equations are
estimated:
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D30ht = α+ β1D30h(t−n) + β2
￿
Xht + β3
￿
Xh(t−1) + β4Hht + ￿ht (2)
D365ht = α+ β1D365h(t−n) + β2
￿
Xht + β3
￿
Xh(t−1) + β4Ht + ￿ht (3)
R28ht = α+ β1D30ht + β2R28h(t−n) + β3
￿
Xht + β4
￿
Xh(t−1) + β5Ht + ￿ht (4)
R365ht = α+ β1D365ht + β2R365h(t−n) + β3
￿
Xht + β4￿Xh(t−1) + β5Ht + ￿ht (5)
where D30ht and D365ht denote the 30-day and 365-day hospital mortality intercepts
gained from the first stage analysis, representing the latent mortality for each hospital
h at year t, and where R28ht and R365ht denote the 30-day and 365-day term hospital
readmission intercepts, representing latent readmissions for each hospital h at year t. The
lag variables D30h(t−n) and D365h(t−n) take into account the latent mortality measures of
n years prior to year t, while variables X1 and X2 control for hospital type and treatment
characteristics of the hospital such as average length of stay of patients, number of cases
admitted and average waiting time). Ht represents yearly dummies which are intended to
capture any contemporaneous shocks that may influence quality.
In any model that includes a lagged dependent variable there is an inherent problem of
autocorrelation, which is magnified when the time-series dimension of the data is small
(Nickell, 1981). The problem arises because of the correlation of the lagged dependent
variable and the error term, and results in making the estimators inconsistent. Including
additional regressors does not remove this bias, and if they are correlated with the lagged
dependent variable their coeﬃcients may also be seriously biased. This problem can be
addressed by estimating a dynamic panel data model, which uses the first diﬀerenced
Generalized Method of Moments (GMM) estimator (Arellano and Bond, 1991). However,
the Arellano-Bond estimator may not perform well if the autoregressive parameters are too
large and the time series observations are moderately small. This problem is addressed by
the later work of Arellano and Bover (1995) and Blundell and Bond (1998) which impose
additional restrictions on the initial conditions process. The Blundell-Bond estimator
is used in this analysis, given the small time-series component available in the newly
constructed panel dataset. In addition the Blundell-Bond estimator is able to incorporate
lagged levels as well as lagged diﬀerences, which increases the eﬃciency of the model by
allowing us to add additional instruments such as hospital characteristics.
The xtabond2 command in statistical package STATA is used to perform the analysis.
A two-step estimator was used, as it is asymptotically more eﬃcient. Robust standard
errors were requested, which ensures that the xtabond2 command includes a finite-sample
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correction to the two-step covariance matrix derived by Windmeijer (2005), which can
make two-step robust estimations more eﬃcient than one-step robust, especially for system
GMM, with lower bias and lower standard errors. Following the recommendations made
by Roodman (2006) the model is specified so that every repressor is included in instrument
matrix, with endogenous variables, such as the lagged dependent variable, specified from
two lags, and exogenous predetermined variables specified from one or two lags. Finally,
the xtabond2 command reports the results of the Arellano-Bond AR(1) and AR(2) tests
for autocorrelations, as well as the Sargan and Hansen test statistics which indicate how
well specified the model is.
3 Data
The data used to conduct this analysis is Hospital Episode Statistics (HES) which docu-
ments hospital activity in England. The HES database has been in existence since 1987
and is/has been used by the Department of Health to provide performance information
at the hospital level (Spiegelhalter et al., 2002). Hospital episode statistics (HES) contain
records for all NHS patients admitted to English hospitals in each financial year (April 1 to
March 31), with information on all medical and surgical specialties, including private pa-
tients treated in NHS hospital trusts. The HES data holds over 15 million patient records
each year, stored according to the financial year in which the period of care was completed.
Each NHS hospital is required to submit data items for each episode in every patient’s
stay in that hospital. Data is entered from patient’s notes onto hospital administration
systems by trained clinical coders (Aylin et al., 2007).
Diagnosis of patients are coded using ICD-10 (international statistical classification of dis-
eases, tenth revision) codes while procedures use the UK Oﬃce of Population Censuses and
Surveys classification (OPCS4). Since the introduction of the internal market, HES data
has also been used for contracting between purchasers and providers. The data available
in the HES database contains patient characteristic data (e.g. gender, age), clinical infor-
mation (e.g. diagnoses, procedures undergone), mode of admission (emergency, elective),
outcome data (mortality, readmission, discharge location) as well as details on the amount
of time spent in contact with the health system (waiting times, date of admission, date
of discharge) and details of which hospital the patient was treated in. The HES data we
used was accessed through Dr. Foster Intelligence, an independent association dedicated
to providing high quality health information.
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While HES data is a rich source of information, it requires some manipulation in order to
ensure that the total care received by a patient is measured under the same episode. HES
data measures the care received under one consultant during the course of the patient’s
treatment, in the case that the patient is treated by more than one consultant it is impor-
tant to identify such patients and link their records of care to provide a complete picture of
their care experience. Dr. Foster has done the matching within the HES data and is able
to provide information on the complete patient experience. In addition they have linked
to other data sources such as the death registries, to provide additional information such
as death rates at diﬀerent intervals (30-days and yearly), readmission rates and further
details on the patient, such as further information on their co-morbidities and on some
socioeconomic characteristics.
Data on gender and age are used as explanatory variables in the analysis, as is a variable
indicating whether the treatment undergone was an elective procedure. The Charlson co-
morbidity index which predicts the 1 year mortality for a patient who may have a range of
co-morbid conditions was used to control for severity of patients. This index is constructed
by assigning a score to each condition depending on the risk of dying associated with it,
and summing these scores up (Charlson et al., 1987). Finally, socio-economic status was
measured using the Carstairs index of deprivation. This index is based on four census
indicators: low social class, lack of car ownership, overcrowding and male unemployment,
which are combined to create a composite score. The deprivation score is divided into
seven separate categories which range from very low to very high deprivation.
We requested data for seven conditions for the financial years 1996-2008, namely: Acute
Myocardial Infarction (AMI), Myocardial Infarction (MI), other Ischemic Heart Disease
(IHD), Congestive Cardiac Failure (CCF), Stroke, Transient Ischemic attack (TIA) and
Hip Replacement. While the analysis is conducted in this paper, only the results for AMI
and Hip Replacement are presented as these are common conditions and the results are
similar for the other conditions. Some statistics for the other five conditions can be found
in Appendix A. Seven conditions were chosen in order to be able to evaluate how well the
quality measures performed for diﬀerent clinical areas, diﬀerent sample sizes and diﬀerent
type of admissions. The data for these conditions was extracted based on the ICD-10
and OPCS 4.3 classification codes indicated in Table 1 and Table 5. In most cases there
were problems with the sample sizes of some of the years before 2000, and so these years
were not included in the analysis. Any hospital trust that had less than 10 admissions
throughout the entire period of analysis was dropped from the analysis. Moreover, any
primary care trusts, private trusts acting as NHS providers and social care trusts were
also excluded. For the sample of patients admitted with AMI, only emergency admissions
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were examined, and only for patients with a length of stay greater than two days. For
the patients admitted with Stroke and Congestive Cardiac Failure, all patients admitted
as day cases were excluded.
AMI otherwise referred to as a heart attack, refers to an acute blockage of an artery that
provides blood to the heart muscle, it is a major health event that almost always results
in hospitalization. AMI is commonly used for quality assessment purposes because of
the large sample size available, the established link between treatment and survival, and
because it is usually an emergency admission which makes patient selection by providers
diﬃcult. Hip Replacement occurs in instances where the hip joint is surgically replaced
by a prosthetic implant. Hip Replacement surgery can be performed as total replacement
or a half replacement. Total Hip Replacement is defined as the surgical removal of the
entire hip joint (ball and socket) and its replacement by a prosthetic (metal or synthetic
plastic) implant. A half replacement or hemiarthroplasty, being a slightly less invasive
procedure, refers to the replacement of only the ball part of the joint (femoral head).
Hip Replacements can be undertaken as elective conditions, with the vast majority of
such cases being undertaken to treat Arthritis. The procedure may be the result of an
emergency to replace a broken hip. This condition was selected as it is not dominated
by emergency admissions, indeed elective hip arthroplasty are extremely common and
extremely successful. Also Hip Replacement is an easily identifiable condition, which will
be easily coded and provide us with a large sample of patients to work from.
Tab. 1: Summary Statistics of the Sample.
Condition ICD-10/OPCS4.3
codes
Years Analyzed Mean cases per
year
Number of
hospitals
AMI ICD-10: 121 2000-2008 399,560 139
Hip OPCS4.3: W37-W39
W46-W48 W58
1996-2008 40,564 125
To undertake the first analysis outcomes are defined through the use of mortality and
readmission rates at diﬀerent intervals are used as dependent variables. These variables
are directly reported in the data, and represent noisy estimates of hospital outcome. The
model was estimated for 30-day within hospital mortality rates, designed to measure if a
patient dies within up to 30 days in hospital after their initial admission for treatment
(with a value of 1 in the case of death and 0 otherwise), 365-day overall mortality rates,
28-day readmission rates which measure whether a patient is readmitted for the same
condition in a 28 day period (with a value of 1 for readmission and 0 otherwise), and 365
day readmission rates.
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A trust code is used to distinguish each hospital in the data, allowing us to identify which
hospitals are performing better or worse. Data on gender and age are used as explanatory
variables in the analysis, as is a variable indicating whether the treatment undergone was
an elective procedure. The Charlson co-morbidity index was used to control for patient
co-morbidity, and the Carstairs index of deprivation was used to control for socio-economic
status.
The second part of the analysis considers how explanatory variables at the hospital level
influence the latent quality measures. In order to do this we take the latent measures
constructed for every outcome measure, for every year and create a new panel data set
at the hospital level. This data set contains the newly created latent outcome measures
for each year, along with the hospital characteristic information that was available in the
individual data. In addition, it is possible to estimate a set of aggregate variables for
each year in the data corresponding to the average socioeconomic and demographic char-
acteristics of the patients treated by each hospital, such as mean co-morbidity of patients
treated, mean deprivation of patients treated, number of admissions, mean length of stay
and mean waiting times. Again for the sake of brevity, and as the results are generally
similar we concentrate on two sets of results in the paper (AMI and Hip Replacement and
report the others in Appendix A.
4 Results
This paper examines the measurement of quality at the hospital level using the two models
described previously. Model 1 refers to the model used to construct the latent measures
(equation (1)) and Model 2 to the analysis of the latent measures (equations (2)–(5)). The
results are presented for the two models, separately by condition. The results for AMI,
and Hip Replacement, are presented in the results section. The results for the remaining
five conditions are similar in that they demonstrate the methodology is reproducible for
all areas. Some basic results presented in Appendix A, and discussed in the conclusions.
The results for the other five conditions are summarised in Appendix A and full details
can be forwarded if required.
4.1 Model 1
In order to compare how the latent variables perform relative to the raw outcome data we
first present a graphical representation of the average value of the four outcome measures
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being studied (30-day and 365-day mortality; and 28-day and 365-day readmissions) for
each condition. These are indicative of raw outcomes across hospitals, over time, before
any analysis is undertaken. In each of these figures, the dashed lines represent the 95%
confidence intervals of the estimates representing variation among hospitals. These graphs
are useful in order to visually represent the diﬀerence between the latent measures and
the raw measures.
In Model 1, the unit of analysis is the individual patient, and the main focus of interest
is the relationship between individual patient’s death rates/ readmission rates and the
quality of the hospital at which they were treated, controlling for patient characteristics.
In the first model a linear regression is used (estimated separately for each year and each
outcome indicator) to measure the hospital specific eﬀects that contribute to mortality and
readmission rates, controlling for age, gender, deprivation, co-morbidities and whether the
procedure undertaken was elective or emergency. The model is estimated as a regression-
through-the-origin, thus R2 value is not meaningful and not reported. The results of these
regressions are presented for each condition and indicate how each of the control variables
influence the outcomes measured as the dependent variables. The sign and magnitude
for each variable in each regression is as expected, such that age, gender, co-morbidity,
deprivation and type of admission significantly influence outcomes for most conditions.
From the Model 1 regressions, the hospital intercepts are extracted and saved, and used
as a ‘latent outcome measures’ of the unobservable hospital specific eﬀect on mortality
and readmissions. The latent outcome measure averaged across hospitals is graphically
illustrated over time, separately for each outcome measure and condition studied. In
these figures, the solid line represents the mean latent outcome measure of all hospitals
in the sample, over the time period being evaluated, while the dashed lines indicate the
95% confidence intervals for these estimates representing variation among hospitals. If
we imagine hospital quality to be the true underlying signal, surrounded by random,
systematic and measurement error, than each hospital’s intercept indicates the slope of
that curve when graphed over time. As the latent variables are the hospital coeﬃcients
in each of the outcome equations, a negative value indicates a fall in the raw outcome
attributable to unobserved hospital eﬀects, while a positive value indicates a rise in the
raw outcome. While the 95% confidence intervals represent the variation across hospitals.
These diagrams allow us to visualise the average latent measures over time and draw some
conclusions about trends in quality. The latent measures show a clearer change in quality
over time than apparent from the noisy outcome data. This is consistent with the trends
as shown by other risk adjusted measures, such as HSMRs, which indicate that quality is
improving (Hawkes, 2010b).
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In order to observe the trend in latent outcome measures at the hospital level, the time
trend of latent values are illustrated for a selection of four hospitals in each condition,
represented in four panels. Of the four hospitals included, there is always a small hospital
(upper left), a large hospital (lower right), and two midsize hospitals, where size of hospital
is determined relative to the average caseload per year per condition. These hospitals are
not a random sample, but chosen to illustrate the data in diﬀerent settings. The solid line
in each of these panels indicates the latent outcome measure estimated from the linear
model for the selected hospital, while the two dashed lines indicate the 95% confidence
intervals of these estimates. The latent outcome measures have been normalized such that
the mean aggregate outcome value of all hospitals for each year is equal to zero, and any
deviation from the mean indicates above or below average performance for that hospital.
Negative values indicate lower mortality than average, and positive values indicate higher
mortality than average, controlling for patient characteristics. The solid lines can be
interpreted as absolute outcome diﬀerences, for example a value of 0.02 indicates that the
hospital’s mortality was 2% above the average hospital in that year. These figures allow
an interpretation of how the individual hospitals are performing relative to their peers in
all areas evaluated. They indicate that the latent measures are easy to use as performance
indicators at the individual hospital level.
4.1.1 AMI
Figure 1 indicates the trends over time in raw average mortality and readmission rates for
AMI. The trend in average AMI 30-day mortality across hospitals is downward, with short
term mortality falling gradually over time, at a gradual pace. Average 365-day mortality is
also falling, yet while this trend is gradual for most years there is a large sudden drop from
2005 to 2006, which is not present in the 30-day mortality trend. The trend in average
28-day readmissions indicates an almost negligible increase over time. While, average
365-day readmissions stay relatively constant, rising and falling marginally over the time
period studied, such that readmissions at the end of the time period are around the same
level as they were in the beginning.
The regression results from Model 1, presented in Table 2, indicate that patient charac-
teristics such as age, gender, deprivation and co-morbidities are almost always significant
at high levels for all four outcome indicators. Gender significantly impacts mortality and
readmissions, such that women have a marginally higher mortality, and higher readmis-
sion rates, than men. Existing co-morbidities, as measured by the Charlson Co-morbidity
index, significantly increase mortality and readmissions, as do increased deprivation as
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measured by the Carstairs score. Only emergency admissions are considered for AMI, and
so type of admission is not controlled for. Trust dummies included for each hospital and
year are highly significant for all four outcome measures.
Fig. 1: Trends across years in average AMI outcome measures across hospitals.
Tab. 2: Regression results for AMI Model 1.
Year N (total) Age Gender Carstairs Score Co-morbidity Trust dummies
30-Day Mortality
(0.000) (0.003) (0.000) 0.001
2001 43986 0.004*** 0.011*** 3.82E-04 0.037*** yes
(0.000) 0.003 (0.000) -0.001
2002 44619 0.004*** 0.007*** 0.001*** 0.039*** yes
(0.000) 0.003 (0.000) 0.001
2003 44160 0.004*** 0.009*** 8.16e-04* 0.040*** yes
(0.000) 0.003 (0.000) 0.001
2004 43426 0.004*** 0.009*** -2.18E-05 0.035*** yes
(0.000) 0.003 (0.000) 0.001
2005 40186 0.004*** 0.019*** 5.35E-04 0.035*** yes
(0.000) 0.003 (0.000) 0.001
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Year N (total) Age Gender Carstairs Score Co-morbidity Trust dummies
2000 32950 0.004*** 0.006* 0.001** 0.043*** yes
2006 37743 0.003*** 0.002 0.001*** 0.031*** yes
(0.000) 0.003 (0.000) 0.001
2007 36240 0.003*** 0.001*** 1.61E-04 0.032*** yes
(0.000) 0.003 (0.000) 0.001
2008 33607 0.003*** 0.001 4.29E-04 0.031*** yes
(0.000) 0.003 (0.000) 0.001
365-Day Mortality
2000 37346 0.011*** 0.010** 0.004*** 0.090*** yes
(0.000) -0.004 -0.001 -0.002
2001 49780 0.011*** 0.016*** 0.003*** 0.086*** yes
(0.000) -0.004 -0.001 -0.002
2002 50711 0.011*** 0.017*** 0.004*** 0.084*** yes
(0.000) -0.004 -0.001 -0.002
2003 50202 0.011*** 0.027*** 0.004*** 0.086*** yes
(0.000) -0.004 -0.001 -0.002
2004 49762 0.011*** 0.014*** 0.003*** 0.078*** yes
(0.000) -0.004 -0.001 -0.002
2005 46914 0.010*** 0.020*** 0.004*** 0.075*** yes
(0.000) -0.004 -0.001 -0.002
2006 45133 0.006*** 0.012*** 0.003*** 0.042*** yes
(0.000) -0.003 -0.001 -0.002
2007 44026 0.005*** 0.017*** 0.002*** 0.040*** yes
(0.000) -0.003 -0.001 -0.001
2008 41474 0.005*** 0.009*** 0.001** 0.039*** yes
(0.000) -0.003 -0.001 -0.001
28-Day Readmission
2000 32950 4.80e-04*** 0.007* 0.002*** 0.010*** yes
(0.000) -0.004 -0.001 -0.002
2001 43986 5.71e-04*** 0.013*** 0.002*** 0.009*** yes
(0.000) -0.003 -0.001 -0.002
2002 44619 5.40e-04*** 0.011*** 0.001** 0.011*** yes
(0.000) -0.003 -0.001 -0.002
2003 44160 6.64e-04*** 0.022*** 0.001** 0.008*** yes
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Year N (total) Age Gender Carstairs Score Co-morbidity Trust dummies
2000 32950 0.004*** 0.006* 0.001** 0.043*** yes
(0.000) -0.003 -0.001 -0.002
2004 43426 9.75e-04*** 0.008*** 0.002*** 0.011*** yes
(0.000) -0.003 -0.001 -0.002
2005 40186 0.001*** 0.017*** 0.002*** 0.013*** yes
(0.000) -0.004 -0.001 -0.002
2006 37743 0.001*** 0.015*** 0.001 0.014*** yes
(0.000) -0.004 -0.001 -0.002
2007 36240 0.001*** 0.016*** 0.003*** 0.015*** yes
(0.000) -0.004 -0.001 -0.002
2008 33607 0.001*** 0.017*** 0.002*** 0.013*** yes
(0.000) -0.004 -0.001 -0.002
365-Day Readmission
2000 37346 0.001*** 0.008* 0.005*** 0.018*** yes
(0.000) -0.005 -0.001 -0.003
2001 49780 0.001*** 0.022*** 0.007*** 0.020*** yes
(0.000) -0.004 -0.001 -0.002
2002 50711 0.001*** 0.017*** 0.005*** 0.021*** yes
(0.000) -0.004 -0.001 -0.002
2003 50202 0.002*** 0.026*** 0.005*** 0.018*** yes
(0.000) -0.004 -0.001 -0.002
2004 49762 0.002*** 0.023*** 0.005*** 0.020*** yes
(0.000) -0.004 -0.001 -0.002
2005 46914 0.001*** 0.026*** 0.005*** 0.022*** yes
(0.000) -0.004 -0.001 -0.002
2006 45133 0.001*** 0.030*** 0.004*** 0.022*** yes
(0.000) -0.004 -0.001 -0.002
2007 44026 0.002*** 0.027*** 0.006*** 0.022*** yes
(0.000) -0.004 -0.001 -0.002
2008 41474 0.002*** 0.029*** 0.004*** 0.020*** yes
(0.000) -0.004 -0.001 -0.002
* Significant at p ≤ 0.1
** Significant at p ≤ 0.05
*** Significant at p ≤ 0.01
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Figure 2 shows the trends over time in average latent mortality and readmission rates for
AMI, such that the curve in each panel represents the rate of change in the raw outcomes
over time controlling for patient characteristics. The mean hospital latent mortality out-
comes are negative for both 30-day and year-long mortality, indicating that on average
rate of change in mortality attributable to each hospital is decreasing. However, for both
outcomes the values are becoming more positive over time, meaning that the mean is
decreasing at an increasing rate. The confidence intervals for 30-day mortality show a
variation of just under 2% in the beginning of the sample, which narrow after 2005 to
about 1%. This indicates less variation in the quality of hospitals towards the end of the
time period. The panels for readmissions are mostly positive, indicating increasing read-
missions attributable to hospital performance are increasing, on average. However, in both
readmission panels the points are approaching zero indicating that they are increasing at
a decreasing rate. Indeed for 28-day readmissions the value falls below zero for 2007-2008,
indicating decreasing readmissions in this period.
Fig. 2: Trends across years in average latent AMI outcome measures across hospitals.
Figures 3 and 4, show the trend in AMI latent 30-day and 365-day mortality for four
selected hospitals. The confidence intervals for both figures, show more variation in latent
mortality within hospitals than indicated by either of the averages plotted in Figure 2. For
both short term and long term mortality, estimates within hospitals range from over 5%
above average to more than 7% below average. There hospital specific panel indicate year-
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to-year variations of performance, commonly around 3-4% in either direction. Figures 5
and 6 show AMI latent 28-day and 365-day readmissions for the same four hospitals. The
confidence intervals for both readmission figures show about the same degree of within
hospital variation among latent readmissions than was observed for latent mortality, of
about 5%. The magnitude of the year-to-year variation, is also similar, but varies according
to the hospital.
The latent outcome measures graphed by individual hospital allow quality comparisons
to be made between diﬀerent providers, and examination of their own quality trajectory
through time. For example, in Figure 3, the midsize hospital in the bottom left hand
panel is clearly providing above average quality for the entire time period, as the estimate
and the entire 95% confidence interval lie below 0, or the average mortality rate of all
hospitals. However, the trend of the estimate over suggests that while mortality rates are
below average, they are steadily increasing relative to its peers. Looking at the latent long
term mortality rates for the same hospital (Figure 4) indicates that the provider performs
relatively worse on this outcome measure in the later time periods. While 365-day latent
mortality rates started oﬀ below average in 2000, they have steadily increased throughout
the sample until they are unequivocally above average in 2008.
Fig. 3: Trends across years in latent AMI 30-day mortality for selected hospitals.
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Fig. 4: Trends across years in latent AMI 365-day mortality for selected hospitals.
Fig. 5: Trends across years in Latent AMI 28-day readmissions for selected hospitals.
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Fig. 6: Trends across years in latent AMI 365-day readmissions for selected hospitals.
4.1.2 Hip Replacement
Average 30-day mortality for Hip Replacement in the years 1996-2008, presented in Figure
7 exhibits a relatively constant trend during the entire time period. The confidence inter-
vals surrounding the estimate narrow slightly from 2004 onwards, suggesting less variation
in outcomes among hospitals from that point onwards. The average 365-day mortality
rates for Hip Replacement shown in Figure 7 do not display a constant trend. Instead
there is a noticeable increase from the year 1999 which is sustained until 2006, where
mortality returns to its 2008 level. Similar to Figure 1, the confidence intervals surround-
ing the estimate narrow from 2005 onwards. Average 28-day and 365-day readmissions
for Hip Replacement both show a slight upwards trend throughout the 2000-2008 period.
In both figures there is a widening of confidence intervals in the year 2001, suggesting
a larger variation in readmissions amongst hospitals for that year. For average 365-day
readmissions only, there is sharp increase from 2006-2007.
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Fig. 7: Trends across years in average Hip Replacement outcome measures across hospitals.
Table 3 presents the regression results from Model 1 for all four outcome indicators. In
both mortality regressions age, gender, co-morbidity and type of admission is significant
such that higher age and co-morbidity leads to increased mortality. In addition, women
have a marginally higher mortality than men, and non-elective admissions have higher
mortality than elective admissions. Deprivation is significant for only some of the years in
both regressions. Where significant, higher deprivation is associated with higher mortality.
The trust dummies were always significant. All the explanatory variables included in the
28-day and 365-day readmissions models were significant, such that older patients, more
deprived patients and patients with co-morbidities had higher rates of readmissions in
addition to women and patients that were admitted for elective procedures.
Tab. 3: Regression results for hip Model 1.
Year N (total) Age Gender Carstairs
Score
Co-morbidity Elective Trust
dummies
30-Day Mortality
1996 25835 4.29e-04*** 0.004*** -2.12e-04 0.021*** 0.015*** yes
(0.000) (0.001) (0.000) (0.001) (0.002)
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Year N (total) Age Gender Carstairs
Score
Co-morbidity Elective Trust
dummies
1997 29952 4.12e-04*** 0.002** -2.48e-04 0.019*** 0.017*** yes
(0.000) (0.001) (0.000) (0.001) (0.002)
1998 34559 5.34e-04*** 0.004*** 2.44e-04 0.020*** 0.015*** yes
(0.000) (0.001) (0.000) (0.001) (0.001)
1999 36527 4.41e-04*** 0.002** 1.81e-04 0.020*** 0.019*** yes
(0.000) (0.001) (0.000) (0.001) (0.001)
2000 36864 4.55e-04*** 0.004*** 5.31e-05 0.017*** 0.014*** yes
(0.000) (0.001) (0.000) (0.001) (0.001)
2001 38745 4.47e-04*** 0.002** 4.20e-04** 0.015*** 0.016*** yes
(0.000) (0.001) (0.000) (0.001) (0.001)
2002 41502 4.39e-04*** 0.002** 4.73e-04*** 0.017*** 0.015*** yes
(0.000) (0.001) (0.000) (0.001) (0.001)
2003 44759 4.68e-04*** 0.001 9.38e-05 0.017*** -0.011*** yes
(0.000) (0.001) (0.000) (0.001) (0.001)
2004 47124 3.87e-04*** 0.003*** 2.24e-04 0.012*** -0.012*** yes
(0.000) (0.001) (0.000) (0.001) (0.001)
2005 46507 4.06e-04*** 0.002*** 1.52e-04 0.013*** -0.013*** yes
(0.000) (0.001) (0.000) (0.001) (0.001)
2006 45438 3.76e-04*** 0.003*** 1.39e-04 0.013*** -0.013*** yes
(0.000) (0.001) (0.000) (0.000) (0.001)
2007 47232 3.64e-04*** 0.002*** 1.26e-04 0.011*** -0.011*** yes
(0.000) (0.001) (0.000) (0.000) (0.001)
2008 48243 3.35e-04*** 0.002*** 1.29e-04 0.008** -0.008*** yes
(0.000) (0.001) (0.000) (0.000) (0.001)
365-Day Mortality
1996 25835 0.001*** 0.005*** -1.64e-04 0.033*** 0.030*** yes
(0.000) (0.001) (0.000) (0.001) (0.002)
1997 29952 0.001*** 0.003*** -1.59e-04 0.032*** 0.028*** yes
(0.000) (0.001) (0.000) (0.001) (0.002)
1998 34559 0.001*** 0.005*** 3.10e-04 0.028*** 0.026*** yes
(0.000) (0.001) (0.000) (0.001) (0.002)
1999 36527 0.001*** 0.002** 3.41e-04 0.026*** 0.029*** yes
(0.000) (0.001) (0.000) (0.001) (0.002)
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Year N (total) Age Gender Carstairs
Score
Co-morbidity Elective Trust
dummies
2000 36864 0.002*** 0.010*** 3.00e-04 0.057*** 0.064*** yes
(0.000) (0.002) (0.000) (0.002) (0.003)
2001 38745 0.002*** 0.006*** 0.002*** 0.059*** 0.089*** yes
(0.000) (0.002) (0.000) (0.002) (0.003)
2002 41502 0.002*** 0.004** 0.002*** 0.054*** 0.079*** yes
(0.000) (0.002) (0.000) (0.002) (0.003)
2003 44759 0.002*** 0.003* 0.001*** 0.058*** 0.082*** yes
(0.000) (0.002) (0.000) (0.002) (0.003)
2004 47124 0.002*** 0.007*** 0.002*** 0.058*** 0.077*** yes
(0.000) (0.002) (0.000) (0.002) (0.003)
2005 46507 0.002*** 0.005*** 0.001*** 0.044*** 0.070*** yes
(0.000) (0.002) (0.000) (0.001) (0.002)
2006 45438 0.001*** 0.004*** 2.88e-04 0.019*** 0.028*** yes
(0.000) (0.010) (0.000) (0.001) (0.001)
2007 47232 0.001*** 0.003*** 2.46e-04 0.014*** 0.021*** yes
(0.000) (0.001) (0.000) (0.001) (0.001)
2008 48243 0.001*** 0.002*** 3.76e-04** 0.010*** 0.023*** yes
(0.000) (0.001) (0.000) (0.001) (0.001)
28-Day Readmission
1996 25835 4.63e-04*** 0.014*** 0.001 0.008*** 0.053*** yes
(0.000) (0.003) (0.001) (0.003) (0.005)
1997 29952 5.13e-04*** 0.009*** 0.002** 0.009*** 0.046*** yes
(0.000) (0.003) (0.001) (0.003) (0.004)
1998 34559 4.36e-04*** 0.018*** 0.002** 0.008*** 0.053*** yes
(0.000) (0.003) (0.001) (0.003) (0.004)
1999 36527 6.01e-04*** 0.013*** 1.23e-04 0.014*** 0.055*** yes
(0.000) (0.003) (0.001) (0.003) (0.004)
2000 36864 5.99e-04*** 0.012*** 0.2e-06*** 0.008*** 0.052*** yes
(0.000) (0.003) (0.001) (0.003) (0.004)
2001 38745 9.41e-04*** 0.0017** 0.002*** 0.006*** 0.059*** yes
(0.000) (0.003) (0.001) (0.002) (0.004)
2002 41502 7.54e-04*** 0.013*** 0.002*** 0.006*** 0.070*** yes
(0.000) (0.002) (0.001) (0.002) (0.001)
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Year N (total) Age Gender Carstairs
Score
Co-morbidity Elective Trust
dummies
2003 44759 8.63e-04*** 0.014*** 0.002*** 0.011*** 0.067*** yes
(0.000) (0.003) (0.001) (0.002) (0.001)
2004 47124 9.01e-04*** 0.016*** 0.002*** 0.006*** 0.068*** yes
(0.000) (0.002) (0.001) (0.002) (0.001)
2005 46507 9.55e-04*** 0.018*** 0.002*** 0.012*** 0.066*** yes
(0.000) (0.003) (0.001) (0.002) (0.001)
2006 45438 0.001*** 0.019*** 0.002*** 0.011*** 0.068*** yes
(0.000) (0.003) (0.001) (0.002) (0.001)
2007 47232 0.001*** 0.014*** 0.003*** 0.013*** 0.075*** yes
(0.000) (0.003) (0.001) (0.002) (0.001)
2008 48243 0.001*** 0.014*** 0.003*** 0.011*** 0.076*** yes
(0.000) (0.002) (0.001) (0.002) (0.001)
365-Day Readmission
1996 25835 0.002*** 0.013*** 0.002** 0.026*** 0.164*** yes
(0.000) (0.005) (0.001) (0.005) (0.007)
1997 29952 0.002*** 0.017*** 0.003*** 0.021*** 0.147*** yes
(0.000) (0.004) (0.001) (0.004) (0.006)
1998 34559 0.002*** 0.025*** 0.004*** 0.023*** 0.152*** yes
(0.000) (0.004) (0.001) (0.004) (0.006)
1999 36527 0.002*** 0.016*** 0.002*** 0.023*** 0.159*** yes
(0.000) (0.004) (0.001) (0.004) (0.006)
2000 36864 0.002*** 0.011*** 0.003*** 0.022*** 0.167*** yes
(0.000) (0.004) (0.001) (0.004) (0.005)
2001 38745 0.002*** 0.0124*** 0.004*** 0.018*** 0.165*** yes
(0.000) (0.004) (0.001) (0.003) (0.005)
2002 41502 0.002*** 0.011*** 0.003*** 0.018*** 0.185*** yes
(0.000) (0.004) (0.001) (0.003) (0.005)
2003 44759 0.002*** 0.012*** 0.004*** 0.027*** 0.184*** yes
(0.000) (0.003) (0.001) (0.003) (0.005)
2004 47124 0.002*** 0.015*** 0.005*** 0.017*** 0.178*** yes
(0.000) (0.003) (0.001) (0.003) (0.005)
2005 46507 0.002*** 0.017*** 0.004*** 0.022*** 0.164*** yes
(0.000) (0.003) (0.001) (0.003) (0.005)
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Year N (total) Age Gender Carstairs
Score
Co-morbidity Elective Trust
dummies
2006 45438 0.002*** 0.013*** 0.003*** 0.018*** 0.165*** yes
(0.000) (0.003) (0.001) (0.003) (0.005)
2007 47232 0.003*** 0.006* 0.006*** 0.026*** 0.186*** yes
(0.000) (0.003) (0.001) (0.003) (0.005)
2008 48243 0.002*** 0.015*** 0.005*** 0.024*** 0.174*** yes
(0.000) (0.003) (0.001) (0.002) (0.005)
* Significant at p ≤ 0.1
** Significant at p ≤ 0.05
*** Significant at p ≤ 0.01
Figure 8 shows the average Hip Replacement 30-day latent outcome estimates across hos-
pitals in the time period 1996-2008. Both mortality estimates are negative throughout the
period being investigated. This indicates that on average, the rate of change in mortality,
controlling for patient characteristics is falling. For both short and long term mortality,
the trajectory of the average hospital intercept indicates that initially the rate of change is
decreasing at an increasing rate, but after 2000 it begins to decrease at a decreasing rate.
This pattern is much more pronounced for year-long mortality than 30-day mortality. It
is also apparent in both panels that the confidence intervals at the end of the period are
narrower than in the first years of the sample.
The hospital intercepts for both readmission estimates vary around zero. The aver-
age latent outcome for 28-day readmissions indicates increasing average readmissions at-
tributable to hospital performance, but at a declining rate. Around 2001, the average
becomes negative, indicating that hospitals are contributing towards declining readmis-
sions. The average latent outcomes estimated from 365-day readmissions are negative for
all years but 1997, indicating that throughout the period readmissions are falling. As
the values are becoming increasingly more negative we can say that they are falling at a
decreasing rate.
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Fig. 8: Trends across years in average latent Hip Replacement outcome measures across hospitals.
Figures 9 – 12 show the latent mortality and readmission estimates for four selected hospi-
tals treating Hip Replacement patients. The within hospital and year-to-year variation in
latent mortality is smaller than all other conditions aside from Hip Replacement, ranging
around 1− 5% below and above both 30-day aggregate mortality and 28-day readmission
measures, and around 5− 10% below and above the 365-day aggregate mortality and ag-
gregate readmission measures. While there is year-to-year variation this is usually around
2 − 4% in either direction. There is wider variation in the confidence interval and the
year-to-year variation for the small hospital for all conditions.
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Fig. 9: Trends across hospitals in latent Hip 30-day mortality for selected hospitals.
Fig. 10: Trends across years in latent Hip 365-day mortality for selected hospitals.
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Fig. 11: Trends across years in latent Hip 28-day readmissions for selected hospitals.
Fig. 12: Trends across years in latent Hip 365-day readmissions for selected hospitals.
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4.2 Model 2
The second model uses the aggregate outcome measures as dependent variables to test for
fundamental relationships amongst outcomes and hospital characteristics. Table 4 presents
the results for the regressions estimated for Model 2, one for each of the aggregate outcome
measures, for each condition, run separately for AMI and Hip Replacement. The number
of instruments for each model is reported together with the regression results. As only an
emergency AMI conditions were included in the sample, waiting times and lagged waiting
times were not included in any of the AMI models. Additionally, diﬀerent specifications of
the models were run for the diﬀerent conditions, and the one which best met model fit cri-
teria is reported. For this reason lagged waiting times and length of stay are sometimes not
included in selected models. Most models passed the AR(1) test for autocorrelation with
over 95% confidence. All models also passed the Sargan test for instrument validity with
over 95% confidence, rejecting the null hypothesis that the overidentifying assumptions are
valid. The models indicate that few hospital characteristics are significant in influencing
the change in latent outcomes over time. However, for most conditions some element of
performance is dynamic – demonstrating that change does not occur instantaneously but
is incremental.
Tab. 4: Model 2 regression results for AMI and Hip Replacement.
AMI
D30ht
Hip
D30ht
AMI
D365ht
Hip
D365ht
AMI
R28ht
Hip
R28ht
AMI
R365ht
Hip
R365ht
L. Latent 0.961*** -0.603*** -0.194 -0.450*** -0.0775 -0.0459 -0.448*** -0.821
Mortality (0.209) (0.103) (0.181) (0.111) (0.0589) (1.247) (0.149) (0.527)
L. Latent - - - - 0.210 0.0894 -0.220** 0.0497
Readmissions (0.313) (0.205) (0.110) (0.183)
L. LOS 0.00738*** -0.00147* 0.00471*** -
0.00421***
-0.000251 -0.00113 0.00132** -0.00107
(0.00113) (0.000815) (0.00100) (0.00149) (0.000389) (0.00131) (0.000560) (0.00235)
L. Cases -0.000188 6.09e-05** 0.000250 0.000103 -1.52e-05 3.66e-05 -5.91e-06 3.14e-06
(0.000394) (3.01e-05) (0.000185) (7.49e-05) (1.60e-05) (6.13e-05) (2.74e-05) (2.09e-05)
L. Waiting - 2.56e-05 - 0.000144 - -5.10e-05 - -4.33e-05
Times - (4.97e-05) (9.69e-05) (0.000133) - (0.000164)
Cases -0.000329 -5.47e-05 -0.00110** -0.000138 1.93e-05 5.87e-05 3.56e-05 2.53e-05
(0.000525) (3.85e-05) (0.000529) (8.79e-05) (1.56e-05) (0.000102) (2.40e-05) (4.06e-05)
Cases2 5.92e-07 -7.12e-09 7.83e-07* 3.34e-08 - - - -
(6.63e-07) (2.42e-08) (4.35e-07) (4.65e-08)
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AMI
D30ht
Hip
D30ht
AMI
D365ht
Hip
D365ht
AMI
R28ht
Hip
R28ht
AMI
R365ht
Hip
R365ht
LOS -0.0111*** 0.00240** 0.00506** 0.00780*** -0.000906 0.00517** -0.00206 0.00740
(0.00144) (0.000940) (0.00231) (0.00211) (0.00114) (0.00241) (0.00215) (0.00642)
Waiting - -2.04e-05 - -0.000146 1.77e-05 -3.11e-05 3.87e-05 1.20e-05
Times - (5.11e-05) - (0.000104) (1.47e-05) (6.60e-05) (2.49e-05) (2.15e-05)
Specialist 0.0603 0.00400 -0.0487 0.0105 -0.000906 0.00295 -0.00135 0.00484
Trust (0.0723) (0.00523) (0.0475) (0.00698) (0.00114) (0.00230) (0.00177) (0.00346)
Foundation -0.00120 -0.000743 -0.00101 -0.00107 0.00507 6.80e-05 -0.000908 3.45e-05
Trust (0.00936) (0.00163) (0.00959) (0.00346) (0.00359) (0.000156) (0.00424) (0.000192)
University -0.00149 -0.00114 -0.0332* -0.00126 -0.0264 -0.00946 -0.00519 -0.0169
Hospital (0.0171) (0.00205) (0.0190) (0.00423) (0.0207) (0.0108) (0.0273) (0.0212)
Constant 0.142 -0.0484*** -0.269** -0.0809*** -0.0138 -0.0283 -0.117** -0.110***
(0.121) (0.00971) (0.106) (0.0185) (0.0215) (0.0442) (0.0568) (0.0350)
Year Dummies Yes Yes Yes Yes Yes Yes Yes Yes
Instruments 22 47 22 47 30 42 25 41
N 986 1,047 986 1,047 986 1,047 986 1,047
Groups (hospitals) 132 121 132 121 132 121 132 121
* Significant at p ≤ 0.1
** Significant at p ≤ 0.05
*** Significant at p ≤ 0.01
4.2.1 AMI
Table 4 presents the results for the regressions run for Model 2, using the AMI latent
outcome measures as dependent variables. The results suggest that an increase in lagged
30-day mortality is associated with higher 30-day mortality and lower 1-year readmissions.
Aside from lagged mortality, the only other variables found to be significantly related to
30-day mortality were length of stay and lagged length of stay. Where lagged length of
stay has a significant negative association, such that higher LOS and length of stay a
significant positive association. In the model for long term AMI mortality, length of stay
and lagged length of stay were also significant, but both had a positive association, such
that higher length of stay is associated with higher 1-year mortality estimates. Lagged
caseload is negatively associated with year long mortality, such that more cases are associ-
ated with higher 1-year mortality. In addition, teaching hospitals were significantly related
to lower 1-year mortality than acute care trusts, but with 90% significance. The results
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using short term readmissions as a dependent variable show no significant associations.
While the results for the year-long readmissions model indicate that lagged readmissions,
lagged length of stay and lagged mortality are all associated with the dependent variables.
The direction of the results suggests that higher lagged readmissions will lead to lower
readmissions, and higher lagged length of stay will lead to higher 1-year readmissions.
4.2.2 Hip Replacement
Table 4 shows the Model 2 results for the Hip Replacement latent outcome measures. The
results indicate that 30-day mortality has a negative and significant relationship with past
mortality. Current and lagged length of stay are also significantly associated with 30-day
mortality, such that higher lagged length of stay is associated with lower 30-day mortality,
while higher length of stay is associated with higher 30-day mortality. In addition caseload
is significant, such that it has a positive association with 30-day mortality. The results
for year-long mortality indicate similar results. Lagged year-long mortality is significantly
associated with year-long mortality, such that an increase in lagged mortality results in
lower mortality. Length of stay and lagged length of stay are also significantly associated
with year-long mortality, indicating a positive and negative association respectively. The
regression results for readmissions, indicate fewer significant explanatory variables. The
only significant variable in the 28-day readmission model is length of stay where higher
length of stay is associated with higher readmissions. There are no significant variables in
when the year-long readmission outcome is used as the dependent variable.
5 Discussion
This paper focuses on the need to develop more sensitive indicators to measure the quality
of health care providers. Performance measurement is increasingly being used by stake-
holders such as managers, politicians, regulators, researchers, service users and the general
public to inform their decision making – whether this be individual choices or broader
health policy decisions. While increasingly process and structure measures are being used
in quality measurement, outcome measures remain lucrative in their ability to present a
simple, all-encompassing measure of health care eﬀorts. Hitherto, stakeholders have relied
on raw or risk-adjusted outcome measures as indicators of organizational quality. Yet,
these types of indicators are largely determined by exogenous factors such as patient char-
acteristics, and often risk-adjustment techniques are highly sensitive to technical choices
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which can bias measures in diﬀerent directions depending on the risk adjustment method
selected.
The method applied in this paper employs a systematic approach for evaluating hospital
quality using outcome indicators. This approach assumes a latent hospital level variable
that is unmeasured but includes all of the unobserved factors influencing hospital quality.
It is captured by vectors of hospital level intercepts estimated from individual patient level
equations measuring determinants of outcomes for seven diﬀerent conditions across hospi-
tals. These intercepts, or ‘latent outcome measures’ will thus exclude known confounding
patient level variables, but reflect factors such as unmeasured resources, environmental
and organizational characteristics as well as random error and data imperfections. They
can then be used to explain how much unobserved hospital eﬀects contribute to changes
in mortality and readmission in any given year. Closely observing the trend of the latent
outcome measures over time allows for a better examination of the rate of change in hos-
pital quality than the examination of raw outcome measures, that can be of practical use
to individual providers or policy makers.
The average latent mortality estimates, plotted over time, show the rate of change in
outcomes over time, controlling for patient characteristics. The AMI and Hip Replace-
ment outcomes indicated that for most years, average mortality attributable to hospital
quality is declining. This is also the case for the other conditions studied, as indicated
in Appendix A. In most cases, the rate of decline appears to slow from 2005 onwards.
This is especially pronounced for the year-long mortality measures in all conditions, and
for 30-day mortality intercepts in AMI and Hip Replacement. The trends in readmissions
vary more by condition. The average of the hospital intercepts suggest increasing read-
missions for AMI and decreasing readmissions for Hip Replacement. While this paper has
not used these measures to investigate the possible factors that could be responsible for
these changes, it is likely that policy changes in this time associated with the introduction
of Payment by Results and increased competition play some role, either in terms of the
eﬀects they have on quality through incentives or more likely on the eﬀect they have on
coding of mortality. Under this payment scheme, hospital revenue is very closely linked
to coding. This may result in better coding, but also can lead to adverse behaviours
such as miscoding or fraud. Discrepancies in coding practices have recently been reported
in the literature, such as hospitals coding deaths as palliative care in order to reduce
mortality rates (Hawkes, 2010a). Further in-depth investigation is necessary to draw any
conclusive results. Given the concerns about mortality coding, future estimates using this
methodology would benefit from considering palliative outcomes in addition to mortality
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and readmission rates at diﬀerent levels, or controlling for palliative care by including it
in the explanatory variables of the patient level regressions.
Another interesting observation for many of the average latent estimate plots is that the
diﬀerence between the coeﬃcients from one year to the next, which indicate the absolute
rate of change in mortality. Thus an increase of 0.02 in the average mortality intercept
from one year to the next means that the mortality attributable to hospital quality in-
creased by 2% over that time period. This information can allow us to make important
conclusions about changes over time, controlling for patient factors. Finally, the confi-
dence intervals often become narrower for the mortality intercepts, and either wider or
narrower for the readmissions estimates. This suggests that the variation amongst relative
hospital performance in any given year is also changing. Again this may be linked to poli-
cies occurring during this time period, and perhaps indicate a need to examine possible
explanatory factors.
The latent outcome measures can also be examined at the individual hospital level. Inves-
tigating the outcome measures at this level of analysis provides more information on how
hospitals are performing relative to each other. The results indicate that where there is
suﬃcient sample size these estimates can be informative and quite precise in distinguishing
quality trends over time, and relative to peers. However, in cases where there is a small
number of patients treated annually, the estimates will be subject to wide year-to-year
fluctuations in quality, and surrounded by wide confidence intervals. Both factors make
it harder to draw conclusive results about the quality of provider, making it diﬃcult to
draw any conclusions with an adequate degree of certainty. This suggests that the best
sample with which to conduct this type of analysis at the hospital level is for conditions
where there are large number of patients, provided at many hospitals in the country.
The final part of the analysis of this paper examined the latent outcome measures to
determine how much they can be explained by known hospital characteristics. One of the
main areas of interest of this section was to determine how dynamic hospital outcomes
are. The regression results produced mixed findings. Both AMI and Hip Replacement
indicate that past 30-day mortality is an important determinant of current mortality, but
only for Hip Replacement is year-long mortality also dynamic. In the readmission models,
only long term AMI readmissions are influenced by lagged readmissions.
In general, there appear to be two ways in which past performance can influence cur-
rent performance: through positive association or a negative association. The first way, a
positive association, occurs when good/bad past performance is a predictor of continuing
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good/bad performance. This can be best explained through a notion of path dependency,
where hospitals performing a certain way in one period are likely to continue to do so
regardless of the characteristics of the patients admitted. The second way, as indicated by
a negative association, occurs where past good/bad past performance is associated with
bad/good current performance. This can be regarded as a process of change. Where bad
performance precedes good performance, we can conceptualise this as a process of im-
provement, where poor outcomes in one period motivate internal change so that outcomes
will improve in the next period. Where good performance precedes bad performance, we
can consider this change an indication of decline.
In the 30-day mortality model AMI lagged AMI and current AMI had a positive associa-
tion, suggesting path dependency. For the 30-day Hip Replacement model the association
between past and current mortality is negative, suggesting there has been change over
time. The average trend in latent 30-day mortality indicated in Figure 8 suggest that
mortality is improving over the time period studied, thus the negative association is in-
dicative of an improvement. The results from the year-long mortality regression model,
and Figure 8 also indicate a dynamic eﬀect indicating an improvement in performance.
Unlike the mortality models, the short and long term readmission models were estimated
using two lagged outcome measures to test for a dynamic eﬀect; past readmissions and
past mortality. The positive and negative associations for the lagged readmission variables
can be interpreted in terms of path dependency and change as explained above. However,
the sign on the past mortality variables indicates the association between mortality and
readmissions. Common sense would suggest that high readmissions are an indication of
poor quality, as are high mortality rates. However, this may not always be the case.
High readmissions may also be indicative of good quality where severe patients have been
saved, or even an indication of other factors such as patient lifestyle and behaviour after
discharge.
Only in the AMI model for year-long readmissions were both lagged outcome measures
significant for the same condition. In this case, the negative sign on the lagged readmis-
sion measure suggests change over time. The average latent trend for this AMI outcome,
plotted in Figure 2 indicates increasing readmissions in the beginning of the sample, fol-
lowed by decreasing readmissions in the final year. Thus the negative sign on the lagged
measure is indicating the improvement in readmissions. The negative sign on the lagged
mortality variable indicates that 365-day mortality and 365-day readmissions are nega-
tively correlated, meaning that higher year-long readmissions may not be indicative of
worse performance for this condition. The results for the Hip Replacement model show
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no association between lagged mortality and readmissions, or lagged readmissions and
current readmissions.
The results from Model 2 do not suggest any conclusive findings on how hospital type
influences performance. There are very few specialist trusts in the sample1. However,
specialist trusts were not associated with quality in any of the AMI or Hip Replacement
Models. Indeed, the only type of hospital that was associated with better mortality were
teaching hospitals, but only for year-long AMI outcomes and only with 10% significance.
Of the control variables length of stay and lagged length of stay were significantly as-
sociated with all mortality models, but only a few of the readmissions models. Where
significant in the readmissions models both indicators were always indicative of higher
readmissions. Higher lagged length of stay is associated with worse AMI mortality but
improved hip mortality. While higher same period length of stay is associated with bet-
ter 30-day mortality for AMI and worse 30-day mortality for Hip, and worse year-long
mortality in both conditions.
Caseload also has mixed eﬀect in the diﬀerent models, this could be because good hospitals
get more cases or because too many cases may lead to lower quality. Higher lagged caseload
is associated with higher Hip Replacement 30-day mortality. However, but same period
caseload is positively associated with AMI year-long mortality. Interestingly caseload does
not appear to have a significant eﬀect on readmissions for either condition.
Overall we find that it is diﬃcult to attribute changes in performance to hospital charac-
teristics and exogenous factors using only this analysis. However we are able to identify
areas where past performance is an important predictor of future performance, as well
as areas where the association between diﬀerent outcome measures may be informative
as to their correct interpretation. Moreover, our results suggest that we can distinguish
between two diﬀerent types of dynamic eﬀect, path dependency and change, and identify
the conditions where one occurs instead of the other. Indeed, in the areas where we see
change and not path dependency there is room for further analysis to discover what fac-
tors are motivating this change, and whether it constitutes an improvement or decline in
performance.
We conclude that while the latent variable technique used in this paper does not oﬀer the
solution to quality measurement it is an important addition to the tool box of methods
with which to better understand the hospital contributions to quality of care. The latent
outcome measures provide an interesting way to examine hospital performance over time
1 There were four specialist trusts in the sample and of those two are orthopaedic.
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and relative to one another, provided that they are used for conditions with large sample
size. While the results in this paper only report the results for two of the seven condi-
tions studied, the findings are consistent across conditions. Thus we support that latent
outcomes generated through the latent variable approach provide useful indicators to use
in further analysis of hospital performance. These indicators can be useful in correcting
for methodological bias that arises from using statistical models that combine aggregate
variables (such as hospital mortality rates) with individual observations to determine re-
lationships. In conclusion, while these types of variables may only be only risk adjusted
outcome measures, they provide a straightforward way to present, observe and analyze
outcome data as well as to provide directions for further research.
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A Results for Other Conditions
Tab. 5: Summary Statistics of the Sample.
Condition ICD-10/OPCS4.3
codes
Years Analyzed Mean cases per
year
Number of
hospitals
MI ICD-10: 122,123 2000-2008 7,641 150
IHD ICD-10: 120,125 2000-2008 142,638 119
CCF ICD-10: I11.0, I13.0,
I25.5, I50.0, I50.1,
I50.9, J81X
2000-2008 3,717 122
Stroke ICD-10: I60 - I67 2000-2008 66,866 167
TIA ICD-10:
G45.0-G45.4,
G45.8-G45.9,
G46.0-G46.8
2000-2008 12,433 139
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Fig. 13: Average raw and latent 30-day mortality 2000-2008
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Tab. 6: Model 2 regression results for 30-day Mortality.
MI
D30ht
IHD
D30ht
CCF
D30ht
STROKE
D30ht
TIA
D30ht
L. Latent -0.0711 0.488** -0.0265 0.342** 0.0166
Mortality (0.176) (0.247) (0.121) (0.153) (0.0939)
L. LOS 0.00380 -1.92e-05 -0.000525 0.000656 -1.32e-06
(0.00543) (0.000538) (0.00233) (0.000768) (0.000744)
L. Cases 7.44e-05 3.95e-08 0.000558 -2.08e-05 -5.77e-05
(0.000195) (1.19e-06) (0.000447) (5.98e-05) (7.07e-05)
L. Waiting - - - - 6.51e-07**
Times - - - - (2.85e-07)
Cases 0.000404 -4.86e-07 -0.000966 3.94e-05 2.36e-05
(0.00117) (3.32e-06) (0.00120) (0.000283) (8.79e-05)
Cases2 -9.94e-07 1.84e-10 8.63e-06 -9.43e-09 1.08e-07
(4.38e-06) (9.40e-10) (8.83e-06) (1.96e-07) (1.36e-07)
LOS -0.00525 0.000815 0.00181 - 7.47e-05
(0.0102) (0.00122) (0.00307) - (0.00155)
Waiting 6.53e-06*** -1.91e-06 6.80e-05 3.01e-06 4.81e-06
Times (1.82e-06) (2.44e-06) (0.000148) (1.24e-05) (5.68e-06)
Specialist -0.0373 0.000995 -0.0603*** 0.0384 0.00990***
Trust (0.105) (0.00433) (0.0203) (0.0443) (0.00368)
Foundation 0.00210 -0.000576 0.0167 0.00447 -0.000772
Trust (0.0154) (0.000766) (0.0163) (0.00474) (0.00227)
University 0.0141 -0.000822 -0.0471*** -0.0133 0.000767
Hospital (0.0187) (0.00257) (0.0173) (0.00914) (0.00143)
Constant -0.331** -0.0208 -0.237*** -0.179* -0.0324***
(0.134) (0.0135) (0.0617) (0.0930) (0.00861)
Year Dummies Yes Yes Yes Yes Yes
Instruments 28 33 33 30 34
N 341 919 352 830 509
Groups (hospitals) 105 129 101 125 104
* Significant at p ≤ 0.1
** Significant at p ≤ 0.05
*** Significant at p ≤ 0.01
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